Calling all Librela™ (bedinvetmab injection) families. In partnership with Zoetis, we want to hear how Librela has helped your dog manage osteoarthritis pain. Submit your story below.

Share Your Librela Story

Tell us about your dog and your experience with Librela™ (bedinvetmab injection). Selected stories may be featured on WeRateDogs channels.

* Required fields

Your Dog's Profile

Dog's Name *

Breed *

Gender *

Age (years) *

Experience With Librela *

Dog Photos *

Add up to 6 photos of your dog (JPG, PNG, or GIF — max 15 MB each).

About You

Owner Name *

Owner Email *

City, State *

I own the rights to all the submitted media * I agree to the Terms and Conditions and Privacy Policy * I agree to the Zoetis Terms * By submitting your story, you accept Zoetis Terms of Use, and you warrant and represent that your dog has been diagnosed with osteoarthritis (OA) pain by a licensed veterinarian and has been prescribed Librela™ (bedinvetmab injection) for control of OA pain. *

IMPORTANT SAFETY INFORMATION: See full Prescribing Information at LibrelaPI.com. Librela is for use in dogs only. Women who are pregnant, trying to conceive or breastfeeding should take extreme care to avoid self-injection. Hypersensitivity reactions, including anaphylaxis, could potentially occur with self-injection. Librela should not be used in breeding, pregnant, or lactating dogs. Librela should not be administered to dogs with known hypersensitivity to bedinvetmab. Adverse events reported post-approval include ataxia (lack of balance/coordination), anorexia (loss of appetite), lethargy (tiredness), emesis (vomiting), and polydipsia (increased drinking). The most common adverse events reported in a clinical study were urinary tract infections, bacterial skin infections and dermatitis (skin irritation/inflammation).

Please complete the required fields above.